Rockley Photonics Holdings Ltd

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Rockley is developing a comprehensive range of photonic integrated circuits and associated modules, sensors, and full-stack solutions. From next-generation sensing platforms specifically designed for mobile health monitoring and machine vision to high-speed, high-volume solutions for data communications, Rockley is laying the foundation for a new generation of applications across multiple industries. Rockley believes that photonics will eventually become as pervasive as micro-electronics, and it has developed a platform with the power and flexibility needed to address both mass markets and a wide variety of vertical applications.

SANTA CLARA, Calif.--(BUSINESS WIRE)--Celestial AI™, the Photonic Fabric™ company, today announced the acquisition of silicon photonics intellectual property from Rockley Photonics (Rockley™), including worldwide issued and pending patents. The combination of Celestial AI and Rockley IP results in one of the strongest IP portfolios in the field of silicon photonics for optical compute interconnect, bringing their total IP portfolio to more than 200 patents globally. The acquired patent portfoli.

Celestial AI Acquires Rockley Photonics Patent Portfolio, Strengthening Photonic Fabric™ IP

NEW YORK , Jan. 6, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Rockley Photonics Holdings Limited ("Rockley" or the "Company") (NASDAQ: RKLY; RKLY.W).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rockley Photonics Holdings Limited - RKLY; RKLY.W

SC Health Corp

If you suffered losses exceeding $25,000 investing in SC Health Corporation ("SC Health") (NYSE: SCPE; NYSE: SCPE.WS; NYSE: SCPE.U) and Rockley Photonics Holdings Limited ("Rockley") (NYSE: RKLY; NYSE: RKLY.WS) securities between March 19, 2021 and January 23, 2023, inclusive (the "Class Period") and purchasers directly in the March 2021 private investment in public equity of Rockley shares (the "PIPE Offering") conducted in connection with the merger of SC Health and Rockley (the "Merger")  and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330  (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/RKLY.

ROCKLEY INVESTOR DEADLINE APPROACHING: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In Rockley To Contact Him Directly To Discuss Their Options

NEW YORK , Dec. 28, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Rockley Photonics Holdings Limited ("Rockley" or the "Company") (NASDAQ: RKLY; RKLY.W).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Rockley Photonics Holdings Limited - RKLY; RKLY.W

ROCKLEY SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In Rockley To Contact Him Directly To Discuss Their Options

OXFORD, England & IRVINE, Calif. & PASADENA, Calif.--(BUSINESS WIRE)--Rockley Photonics begins sampling the Bioptx™ Biosensing band and platform for continuous, non-invasive monitoring of spectroscopy-based biomarkers.

Rockley Photonics Begins Sampling Bioptx™ Biosensing Band and Platform

If you purchased or acquired securities in SC Health Corporation ("SC Health") (NYSE: SCPE; NYSE: SCPE.WS; NYSE: SCPE.U) and Rockley Photonics Holdings Limited ("Rockley") (NYSE: RKLY; NYSE: RKLY.WS) securities between March 19, 2021 and January 23, 2023, inclusive (the "Class Period") and purchasers directly in the March 2021 private investment in public equity of Rockley shares (the "PIPE Offering") conducted in connection with the merger of SC Health and Rockley (the "Merger")  and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330  (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/RKLY.

ROCKLEY INVESTOR DEADLINE APPROACHING: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Rockley To Contact Him Directly To Discuss Their Options

NEW YORK--(BUSINESS WIRE)---- $RKLY #classaction--Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against SC Health Corporation (“SC Health” or “the Company”) (NYSE: SCPE; NYSE: SCPE.WS; NYSE: SCPE.U) and Rockley Photonics Holdings Limited (“Rockley” or “the company”) (NYSE: RKLY; NYSE: RKLY.WS) and certain of its officers. Class Definition: This lawsuit seeks to recover damages against Defendants for alleged.

SCPE and RKLY INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that SC Health Corporation and Rockley Photonics Holdings Limited Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

NEW YORK--(BUSINESS WIRE)-- #A--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Rockley Photonics Holdings Limited (“Rockley” or the “Company”) (NYSE: RKLY) in the United States District Court for the Central District of California on behalf of all persons and entities who purchased or otherwise acquired Rockley common stock between November 2, 2022 and October 20, 2023, both dates inclusive (the “Clas.

ROCKLEY ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Rockley Photonics Holdings Limited and Encourages Investors to Contact the Firm

OXFORD, England & IRVINE, Calif. & PASADENA, Calif.--(BUSINESS WIRE)--Rockley continues to make rapid progress towards noninvasive glucose sensing using its proprietary silicon photonics platform.

Rockley Photonics Advances Non-Invasive Blood Glucose Monitoring

OXFORD, England & IRVINE, Calif. & PASADENA, Calif.--(BUSINESS WIRE)--Rockley Photonics has launched a first-generation API Developer Platform to capture, enable and integrate rich sensor data for biomarker insights.

Rockley Photonics Launches Developer Platform for Biomarker Data Collection in Free-Living Conditions

OXFORD, England & PASADENA, Calif.--(BUSINESS WIRE)--Rockley Photonics today announced that it has completed a comprehensive financial restructuring and emerged from Chapter 11 after filing for bankruptcy protection in Q1. All of Rockley's material customer relationships remain in place. The company remains on schedule with all programs including its development of remote patient monitoring technology. Rockley continues to see promising results relating to a number of biomarkers, including gluc.

Rockley Photonics Completes Financial Restructure, Emerges from Chapter 11

OXFORD, England & PASADENA, Calif.--( BUSINESS WIRE )--Rockley Photonics Holdings Limited (NYSE: RKLY) (“Rockley”), a global medical technology company focused on delivering leading edge silicon photonics-based biosensing solutions by targeting a portfolio of biomarkers, today announced that it received 12.9 million pounds sterling ($15.5 million) for its fiscal 2020 R&D tax credit from HMRC, the tax agency of the UK government. The Company filed its fiscal 2021 R&D tax credit application and expects to file its fiscal 2022 R&D tax credit application in 2023.

Rockley Photonics Receives 2020 UK R&D Tax Credit and Files 2021 R&D Tax Credit Application

OXFORD, England, & PASADENA, Calif.--( BUSINESS WIRE )--Rockley Photonics Holdings Limited (NYSE: RKLY) (“Rockley”), a global medical technology company focused on delivering leading edge silicon photonics-based biosensing solutions by targeting a portfolio of biomarkers, today announced that it received a notice from the New York Stock Exchange (“NYSE”) on December 9, 2022, indicating that the Company is not in compliance with NYSE's continued listing standards, which require an average market capitalization of not less than $50 million over a 30 trading-day period and stockholders' equity of not less than $50 million. The notice has no immediate impact on the listing of Rockley's common stock on the NYSE, subject to the Company's compliance with the NYSE's other continued listing requirements, except that its ticker symbol will continue to have an added designation of “.BC” to indicate the status of its ordinary shares as below compliance with the NYSE continued listing standards. The “.BC” indicator will be removed when it regains compliance.

Rockley Photonics Announces Receipt of Notice from NYSE of Non-Compliance with Continued Listing Standards

OXFORD, England & PASADENA, Calif.--( BUSINESS WIRE )--Rockley Photonics Holdings Limited (NYSE: RKLY), a global medical technology company focused on delivering leading edge silicon photonics-based biosensing solutions by targeting a portfolio of biomarkers, today announced changes to its senior management team. These changes are intended to position the Company for its next phase of growth.

Rockley Photonics Announces Promotion of Richard A. (Randy) Meier to Chief Executive Officer

OXFORD, England & PASADENA, Calif.--( BUSINESS WIRE )--Rockley Photonics Holdings Limited (NYSE: RKLY), a global medical technology company focused on delivering leading edge silicon photonics-based biosensing solutions by targeting a portfolio of biomarkers, today announced that Dr. Andrew Rickman, OBE, will join heads of government, senior ministers, and business leaders from across the Commonwealth to participate in the Commonwealth Trade and Investment Summit 2022.

Rockley Photonics' CEO Andrew Rickman to Speak at the Commonwealth Trade and Investment Summit 2022

OXFORD, England & PASADENA, Calif.--( BUSINESS WIRE )--Rockley Photonics Holdings Limited (NYSE: RKLY) (“Rockley”), a global medical technology company focused on delivering leading edge silicon photonics-based biosensing solutions by targeting a portfolio of biomarkers, today announced a groundbreaking 4-Kelvin performance demonstration with its monolithic silicon photonics electro-absorption modulator technology that is key to the development of next-generation cryogenic interconnect technology. This advancement is intended to enable ultra-sensitive image detection and sensing devices to view and capture images more clearly and at longer distances, as well as in low-light situations and enables these devices to have a significantly reduced size and weight.

Rockley Photonics Demonstrates Compact 4-Kelvin Silicon Photonics Modulator Enabling Interconnect Technologies for Ultra-sensitive Image Detection and Sensing Devices

OXFORD, England & PASADENA, Calif.--( BUSINESS WIRE )--Rockley Photonics Holdings Limited (NYSE: RKLY), a global medical technology company focused on delivering leading edge silicon photonics-based biosensing solutions by targeting a portfolio of biomarkers, today announced that it will participate in the following investor conferences.

Rockley Photonics to Present at Upcoming Conferences

Rockley Photonics Holdings Limited (NYSE:RKLY ) Q3 2022 Earnings Conference Call November 9, 2022 5:00 PM ET Company Participants Gwyn Lauber - VP, IR Andrew Rickman - Founder, Chairman, President & CEO Richard Meier - President and CFO Conference Call Participants Quinn Bolton - Needham & Company Paul Silverstein - Cowen and Company Tim Savageaux - Northland Capital Markets Operator Greetings, and welcome to the Rockley Photonics Third Quarter 2022 Earnings Conference Call. At this time, all participants are in listen-only mode.

Rockley Photonics Holdings Limited (RKLY) Q3 2022 Earnings Call Transcript

Rockley Photonics Holdings Limited (RKLY) delivered earnings and revenue surprises of 80.77% and 72.20%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Rockley Photonics Holdings Limited (RKLY) Reports Q3 Loss, Lags Revenue Estimates

Rockley Photonics Reports Third Quarter of Fiscal 2022 Financial Results

Rockley Photonics Announces Date of Third Quarter 2022 Financial Results Release

Rockley Photonics Announces $90.6 Million Private Placement of New Convertible Notes and Warrants and Repurchase of $63.9 Million of Bridge Notes and Existing Convertible Notes

Rockley Photonics Appoints Healthcare Industry Veteran Richard A. “Randy” Meier President and Chief Financial Officer

Rockley Photonics Completes Human Study Demonstrating Promising Intra-Subject Tracking Against Standard Blood Pressure Cuff, Utilizing Its Non-Invasive, Cuffless, and Laser-Based Device

News for Rockley Photonics Holdings Ltd Stock (RKLY)